5-tert-butyl-1-benzofuran;5-tert-butyl-1,3-benzothiazole;5-tert-butyl-1,3-benzoxazole;2-tert-butyl-6-chloroimidazo[1,2-b]pyridazine;2-tert-butyl-3-chloropyrazolo[1,5-a]pyrimidine;2-tert-butyl-5-chloropyrazolo[1,5-a]pyrimidine;2-tert-butyl-5-cyclopropyl-7-(difluoromethyl)pyrazolo[1,5-a]pyrimidine;3-tert-butyl-2-cyclopropylimidazo[1,2-b]pyridazine;2-tert-butyl-7-cyclopropylpyrazolo[1,5-a]pyrimidine;2-tert-butyl-7-(difluoromethyl)-5-methylpyrazolo[1,5-a]pyrimidine;2-tert-butylimidazo[1,2-a]pyrazine;5-tert-butyl-1H-indole;3-tert-butyl-2-methylpyrazolo[1,5-a]pyrimidine;2-tert-butyl-[1,2,4]triazolo[1,5-a]pyrimidine;2-tert-butyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine;3-tert-butyl-2,5,7-trimethylpyrazolo[1,5-a]pyrimidine
C182H228Cl3F7N40O2S — CID 158333268
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-tert-butyl-1-benzofuran;5-tert-butyl-1,3-benzothiazole;5-tert-butyl-1,3-benzoxazole;2-tert-butyl-6-chloroimidazo[1,2-b]pyridazine;2-tert-butyl-3-chloropyrazolo[1,5-a]pyrimidine;2-tert-butyl-5-chloropyrazolo[1,5-a]pyrimidine;2-tert-butyl-5-cyclopropyl-7-(difluoromethyl)pyrazolo[1,5-a]pyrimidine;3-tert-butyl-2-cyclopropylimidazo[1,2-b]pyridazine;2-tert-butyl-7-cyclopropylpyrazolo[1,5-a]pyrimidine;2-tert-butyl-7-(difluoromethyl)-5-methylpyrazolo[1,5-a]pyrimidine;2-tert-butylimidazo[1,2-a]pyrazine;5-tert-butyl-1H-indole;3-tert-butyl-2-methylpyrazolo[1,5-a]pyrimidine;2-tert-butyl-[1,2,4]triazolo[1,5-a]pyrimidine;2-tert-butyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine;3-tert-butyl-2,5,7-trimethylpyrazolo[1,5-a]pyrimidine
5-tert-butyl-1-benzofuran;5-tert-butyl-1,3-benzothiazole;5-tert-butyl-1,3-benzoxazole;2-tert-butyl-6-chloroimidazo[1,2-b]pyridazine;2-tert-butyl-3-chloropyrazolo[1,5-a]pyrimidine;2-tert-butyl-5-chloropyrazolo[1,5-a]pyrimidine;2-tert-butyl-5-cyclopropyl-7-(difluoromethyl)pyrazolo[1,5-a]pyrimidine;3-tert-butyl-2-cyclopropylimidazo[1,2-b]pyridazine;2-tert-butyl-7-cyclopropylpyrazolo[1,5-a]pyrimidine;2-tert-butyl-7-(difluoromethyl)-5-methylpyrazolo[1,5-a]pyrimidine;2-tert-butylimidazo[1,2-a]pyrazine;5-tert-butyl-1H-indole;3-tert-butyl-2-methylpyrazolo[1,5-a]pyrimidine;2-tert-butyl-[1,2,4]triazolo[1,5-a]pyrimidine;2-tert-butyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine;3-tert-butyl-2,5,7-trimethylpyrazolo[1,5-a]pyrimidine (PubChem CID 158333268) has the molecular formula C182H228Cl3F7N40O2S and a molecular weight of 3279.52 g/mol. Its IUPAC name is 5-tert-butyl-1-benzofuran;5-tert-butyl-1,3-benzothiazole;5-tert-butyl-1,3-benzoxazole;2-tert-butyl-6-chloroimidazo[1,2-b]pyridazine;2-tert-butyl-3-chloropyrazolo[1,5-a]pyrimidine;2-tert-butyl-5-chloropyrazolo[1,5-a]pyrimidine;2-tert-butyl-5-cyclopropyl-7-(difluoromethyl)pyrazolo[1,5-a]pyrimidine;3-tert-butyl-2-cyclopropylimidazo[1,2-b]pyridazine;2-tert-butyl-7-cyclopropylpyrazolo[1,5-a]pyrimidine;2-tert-butyl-7-(difluoromethyl)-5-methylpyrazolo[1,5-a]pyrimidine;2-tert-butylimidazo[1,2-a]pyrazine;5-tert-butyl-1H-indole;3-tert-butyl-2-methylpyrazolo[1,5-a]pyrimidine;2-tert-butyl-[1,2,4]triazolo[1,5-a]pyrimidine;2-tert-butyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine;3-tert-butyl-2,5,7-trimethylpyrazolo[1,5-a]pyrimidine.
Molecular Properties
| Compound Name | 5-tert-butyl-1-benzofuran;5-tert-butyl-1,3-benzothiazole;5-tert-butyl-1,3-benzoxazole;2-tert-butyl-6-chloroimidazo[1,2-b]pyridazine;2-tert-butyl-3-chloropyrazolo[1,5-a]pyrimidine;2-tert-butyl-5-chloropyrazolo[1,5-a]pyrimidine;2-tert-butyl-5-cyclopropyl-7-(difluoromethyl)pyrazolo[1,5-a]pyrimidine;3-tert-butyl-2-cyclopropylimidazo[1,2-b]pyridazine;2-tert-butyl-7-cyclopropylpyrazolo[1,5-a]pyrimidine;2-tert-butyl-7-(difluoromethyl)-5-methylpyrazolo[1,5-a]pyrimidine;2-tert-butylimidazo[1,2-a]pyrazine;5-tert-butyl-1H-indole;3-tert-butyl-2-methylpyrazolo[1,5-a]pyrimidine;2-tert-butyl-[1,2,4]triazolo[1,5-a]pyrimidine;2-tert-butyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine;3-tert-butyl-2,5,7-trimethylpyrazolo[1,5-a]pyrimidine |
|---|---|
| PubChem CID | 158333268 |
| Molecular Formula | C182H228Cl3F7N40O2S |
| Molecular Weight | 3279.52 g/mol |
| Exact Mass | 3275.76 |
| IUPAC Name | 5-tert-butyl-1-benzofuran;5-tert-butyl-1,3-benzothiazole;5-tert-butyl-1,3-benzoxazole;2-tert-butyl-6-chloroimidazo[1,2-b]pyridazine;2-tert-butyl-3-chloropyrazolo[1,5-a]pyrimidine;2-tert-butyl-5-chloropyrazolo[1,5-a]pyrimidine;2-tert-butyl-5-cyclopropyl-7-(difluoromethyl)pyrazolo[1,5-a]pyrimidine;3-tert-butyl-2-cyclopropylimidazo[1,2-b]pyridazine;2-tert-butyl-7-cyclopropylpyrazolo[1,5-a]pyrimidine;2-tert-butyl-7-(difluoromethyl)-5-methylpyrazolo[1,5-a]pyrimidine;2-tert-butylimidazo[1,2-a]pyrazine;5-tert-butyl-1H-indole;3-tert-butyl-2-methylpyrazolo[1,5-a]pyrimidine;2-tert-butyl-[1,2,4]triazolo[1,5-a]pyrimidine;2-tert-butyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine;3-tert-butyl-2,5,7-trimethylpyrazolo[1,5-a]pyrimidine |
| SMILES | CC(C)(C)c1c(C2CC2)nc2cccnn12.CC(C)(C)c1cc2nc(C3CC3)cc(C(F)F)n2n1.CC(C)(C)c1cc2nc(Cl)ccn2n1.CC(C)(C)c1cc2nccc(C(F)(F)F)n2n1.CC(C)(C)c1cc2nccc(C3CC3)n2n1.CC(C)(C)c1ccc2[nH]ccc2c1.CC(C)(C)c1ccc2occc2c1.CC(C)(C)c1ccc2ocnc2c1.CC(C)(C)c1ccc2scnc2c1.CC(C)(C)c1cn2ccncc2n1.CC(C)(C)c1cn2nc(Cl)ccc2n1.CC(C)(C)c1nc2ncccn2n1.CC(C)(C)c1nn2cccnc2c1Cl.Cc1cc(C(F)F)n2nc(C(C)(C)C)cc2n1.Cc1cc(C)n2nc(C)c(C(C)(C)C)c2n1.Cc1nn2cccnc2c1C(C)(C)C |
| InChI | InChI=1S/C14H17F2N3.2C13H17N3.C13H19N3.C12H15F2N3.C12H15N.C12H14O.C11H12F3N3.C11H15N3.C11H13NO.C11H13NS.3C10H12ClN3.C10H13N3.C9H12N4/c1-14(2,3)11-7-12-17-9(8-4-5-8)6-10(13(15)16)19(12)18-11;1-13(2,3)11-8-12-14-7-6-10(9-4-5-9)16(12)15-11;1-13(2,3)12-11(9-6-7-9)15-10-5-4-8-14-16(10)12;1-8-7-9(2)16-12(14-8)11(10(3)15-16)13(4,5)6;1-7-5-8(11(13)14)17-10(15-7)6-9(16-17)12(2,3)4;2*1-12(2,3)10-4-5-11-9(8-10)6-7-13-11;1-10(2,3)7-6-9-15-5-4-8(11(12,13)14)17(9)16-7;1-8-9(11(2,3)4)10-12-6-5-7-14(10)13-8;2*1-11(2,3)8-4-5-10-9(6-8)12-7-13-10;1-10(2,3)7-6-9-12-8(11)4-5-14(9)13-7;1-10(2,3)7-6-14-9(12-7)5-4-8(11)13-14;1-10(2,3)8-7(11)9-12-5-4-6-14(9)13-8;1-10(2,3)8-7-13-5-4-11-6-9(13)12-8;1-9(2,3)7-11-8-10-5-4-6-13(8)12-7/h6-8,13H,4-5H2,1-3H3;6-9H,4-5H2,1-3H3;4-5,8-9H,6-7H2,1-3H3;7H,1-6H3;5-6,11H,1-4H3;4-8,13H,1-3H3;4-8H,1-3H3;4-6H,1-3H3;5-7H,1-4H3;2*4-7H,1-3H3;3*4-6H,1-3H3;4-7H,1-3H3;4-6H,1-3H3 |
| InChIKey | GQGOZMACLVTVLR-UHFFFAOYSA-N |
| XLogP | 46.66 |
| TPSA | 443.02 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 42 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 235 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3279.52 |
| LogP ≤ 5 | 46.66 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 42 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158333268 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.